Qiagen has begun enrolling molecular diagnostics laboratories in an early access program for its web-based clinical interpretation tool for next-generation sequencing tests. The tool makes use of its Ingenuity Knowledge Base database and will provide labs with automated scoring, interpretation, and reporting of findings in standardized, HIPAA Safe Harbor-compliant formats, according to the company.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.